Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    evonik-m-2025-09-08

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Menu

    DTP Vaccine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 9Boostrix

    02 4Infanrix, Pediarix

    03 5Infanrix/Pediarix

    04 8Tetrabik

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Boostrix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Boostrix

    United Kingdom
    arrow
    ChemOutsourcing
    Not Confirmed

    GlaxoSmithKline

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2020 Revenue in Millions : 660

    2019 Revenue in Millions : 810

    Growth (%) : -18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Infanrix/Pediarix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Infanrix/Pediarix

    United Kingdom
    arrow
    ChemOutsourcing
    Not Confirmed

    GlaxoSmithKline

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2020 Revenue in Millions : 764

    2019 Revenue in Millions : 1,016

    Growth (%) : -25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Tetrabik

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Tetrabik

    Japan
    arrow
    ChemOutsourcing
    Not Confirmed

    Mitsubishi Tanabe

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2020 Revenue in Millions : 98

    2019 Revenue in Millions : 84

    Growth (%) : 16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Boostrix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Boostrix

    United Kingdom
    arrow
    ChemOutsourcing
    Not Confirmed

    GlaxoSmithKline

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2021 Revenue in Millions : 705

    2020 Revenue in Millions : 652

    Growth (%) : 9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Infanrix/Pediarix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Infanrix/Pediarix

    United Kingdom
    arrow
    ChemOutsourcing
    Not Confirmed

    GlaxoSmithKline

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2021 Revenue in Millions : 735

    2020 Revenue in Millions : 755

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Tetrabik

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Tetrabik

    Japan
    arrow
    ChemOutsourcing
    Not Confirmed

    Mitsubishi Tanabe

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    Main Therapeutic Indication : Vaccine

    Currency : USD

    2021 Revenue in Millions : 90

    2020 Revenue in Millions : 96

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Infanrix, Pediarix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Infanrix, Pediarix

    United Kingdom
    arrow
    ChemOutsourcing
    Not Confirmed

    GSK

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 732

    2021 Revenue in Millions : 735

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Boostrix

    Diphtheria, Tetanus Acellular, and Pertussis

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Boostrix

    United Kingdom
    arrow
    ChemOutsourcing
    Not Confirmed

    GSK

    Diphtheria, Tetanus Acellular, and Pertussis

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 732

    2021 Revenue in Millions : 705

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Tetrabik

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Tetrabik

    Japan
    arrow
    ChemOutsourcing
    Not Confirmed

    Mitsubishi Tanabe

    Diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 70

    2021 Revenue in Millions : 88

    Growth (%) : -20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Boostrix

    DTP Vaccine

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Boostrix

    United Kingdom
    arrow
    ChemOutsourcing
    Not Confirmed

    GSK

    DTP Vaccine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 663

    2022 Revenue in Millions : 732

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF